Author(s)

Hudson Polonini^1*, Clark Zander², Joshua Radke²

¹Global R&D, Fagron, Rotterdam, The Netherlands.
²Fagron US, Saint Paul, USA.

Acne vulgaris is the most common skin condition associated with inflammation of the pilosebaceous unit and affects all ethnic and age groups, independent of sex, nationality, or socioeconomic status. Treatment usually includes oral and/or physical and/or topical interventions—the last can be obtained through commercial preparations in fixed doses or as compounded creams/gels, with personalized qualitative and quantitative composition, to be unique to each patient. In this sense, ready-to-use vehicles play an important role as a timesaving strategy and to ensure maximum results from the treatment. In this paper, we present Cleoderm^TM Clarifying Cream, a ready-to-use, functional semisolid vehicle for acne treatments and topical products for oily skin, to be used by compounding pharmacies. It contains ingredients that can potentiate the effects of the active ingredients added, and has a light and pleasant skin feel. The current body of evidence shows that Cleoderm^TM Clarifying Cream can be an important strategy for compounding personalized acne treatments due to its multiple positive roles on decreasing sebum production, lipid peroxidation, and reactive oxygen species, inhibition of Cutibacterium acnes proliferation, and control of inflammation.

Acne Vulgaris, Personalized Medicine, Cleome gynandra, Dermatology

Polonini, H. , Zander, C. and Radke, J. (2021) CleodermTM Clarifying Cream: A Novel, Topical Vehicle Using Plant-Based Excipients and Actives Targeting Acne and Oily Skin. Journal of Cosmetics, Dermatological Sciences and Applications, 11, 381-399. doi: 10.4236/jcdsa.2021.114031.